Phase II study. Concurrent chemotherapy and radiotherapy with nitroglycerin in locally advanced non-small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase II study. Concurrent chemotherapy and radiotherapy with nitroglycerin in locally advanced non-small cell lung cancer

Published:2014-05 Issue:2 Volume:111 Page:311-315
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Arrieta Oscar,Blake Mónika,de la Mata-Moya María Dolores,Corona Francisco,Turcott Jenny,Orta David,Alexander-Alatorre Jorge,Gallardo-Rincón Dolores

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference32 articles.

1. Center M.M. global cancer statistics, 2011;Jemal;CA Cancer J Clin,2011

2. National consensus of diagnosis and treatment of non-small cell lung cancer;Arrieta;Rev Invest Clin,2013

3. CHARTWEL-Bronchus study group. Final results of the randomized phase III CHARTWEL-trial (ARO 97–1) comparing hyperfractionated-accelerated versus conventionally fractionated radiotherapy in non-small cell lung cancer (NSCLC);Baumann;Radiother Oncol,2011

4. Concomitant radio-chemotherapy based on platin compounds in patients with locally advanced non-small cell lung cancer (NSCLC): a meta-analysis of individual data from 1764 patients;Auperin;Ann Oncol,2006

5. A randomized phase III comparison of standard-dose (60Gy) versus high-dose (74Gy) conformal chemoradiotherapy with or without cetuximab for stage III non-small cell lung cancer: results on radiation dose in RTOG 0617;Bradley;J Clin Oncol,2013

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Screening for ferroptosis genes related to endometrial carcinoma and predicting of targeted drugs based on bioinformatics;Archives of Toxicology;2024-05-17

2. Repurposing radiosensitising medicines for radiotherapy: an overview;BMJ Oncology;2024-01

3. Nitric Oxide Prevents Glioblastoma Stem Cells’ Expansion and Induces Temozolomide Sensitization;International Journal of Molecular Sciences;2023-07-10

4. GTN Enhances Antitumor Effects of Doxorubicin in TNBC by Targeting the Immunosuppressive Activity of PMN-MDSC;Cancers;2023-06-09

5. Nitroglycerin: a comprehensive review in cancer therapy;Cell Death & Disease;2023-05-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3